Sanofi cholesterol drug touted as potential $3 billion blockbuster

[riky]

Sanofi cholesterol drug touted as potential $3 billion blockbuster

By Natalie Huet PARIS (Reuters) - A new cholesterol-lowering drug from Sanofi and Regeneron has the potential to become a $3-billion-dollar-plus blockbuster, according to analysts awaiting imminent late-stage trial results. The drug, dubbed alirocumab, is part of a group of biotech medicines known as PCSK9 inhibitors that offer a new way of fighting the build-up of artery-clogging fatty deposits that put millions of patients worldwide at risk of heart attacks. ...

Source: You are not allowed to view links. Register or Login